Market Overview

AMAG Pharma Names Greg Madison Chief Commercial Officer

Related AMAG
Why AMAG Pharmaceuticals (AMAG) Could Be Positioned for a Slump - Tale of the Tape
AMAG Pharma Announces Publication of Data from Trial of MuGard in the Journal Cancer

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the appointment of Greg Madison as executive vice president and chief commercial officer. Mr. Madison brings a wealth of hands-on commercial experience and extensive leadership skills to AMAG. He joins AMAG from Genzyme Corporation, where he spent the past 12 years in various commercial roles in their renal division, most recently as the division's vice president and general manager.

Posted-In: News Management

 

Related Articles (AMAG)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters